You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

19-120

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in China (HH-120, )

Completed
  • COVID-19
  • Beijing, Beijing, China
  • +3 more
Sep 8, 2023

Coronavirus Disease 2019(COVID-19) Trial in Beijing (HH-120 Nasal Spray)

Recruiting
  • Coronavirus Disease 2019(COVID-19)
  • HH-120 Nasal Spray
  • Beijing, China
    Beijing Ditan Hospital, Capital Medical University
Dec 20, 2022

COVID-19, SARS-CoV-2 Infection Trial in Beijing (HH-120 Nasal Spray)

Completed
  • COVID-19
  • SARS-CoV-2 Infection
  • HH-120 Nasal Spray
  • Beijing, Beijing, China
    Beijing Ditan Hospital,Capital Medical University
Feb 26, 2023

COVID-19 Trial in Beijing (HH-120 nasal spray, PartA cohort 1, HH-120 nasal spray, Part A cohort 2-7, HH-120 nasal spray, Part A

Active, not recruiting
  • COVID-19
  • HH-120 nasal spray, PartA cohort 1
  • +4 more
  • Beijing, Beijing, China
    Beijing TongRen Hospital, Capital Medical University
Feb 23, 2023

COVID-19 Respiratory Infection Trial in Brisbane (HH-120 Dose 1, HH-120 Dose 2, HH-120 Dose 3)

Recruiting
  • COVID-19 Respiratory Infection
  • HH-120 Dose 1
  • +3 more
  • Brisbane, Queensland, Australia
    Nucleus Network
Sep 1, 2022

COVID-19 Trial in China (HH-120 nasal spray, Placebo Comparator)

Recruiting
  • COVID-19
  • HH-120 nasal spray
  • Placebo Comparator
  • Beijing, Beijing, China
  • +14 more
Feb 2, 2023

COVID-19 Trial in Beijing, Shanghai (HH-120 Nasal Spray, Placebo)

Not yet recruiting
  • COVID-19
  • HH-120 Nasal Spray
  • Placebo
  • Beijing, China
  • +1 more
Mar 27, 2023

SARS-CoV-2 Infection Trial in Beijing (HH-120 nasal spray 1, HH-120 nasal spray 2, Placebo Comparator 1)

Completed
  • SARS-CoV-2 Infection
  • HH-120 nasal spray 1
  • +3 more
  • Beijing, Beijing, China
    Beijing Ditan Hospital,Capital Medical University
Mar 1, 2023

COVID-19 Symptoms in "Long Hauler" Patients Who Participated in

Completed
  • COVID-19
  • KB109 + Self Supportive Care
  • Self Supportive Care (SSC) Alone
  • Hot Springs, Arkansas
  • +1 more
Aug 17, 2021

COVID-19 Trial in Chicago (Tocilizumab, Standard of Care)

Recruiting
  • COVID-19
  • Chicago, Illinois
    University of Chicago Medicine
May 11, 2022

COVID Trial in Worldwide (NP-120 (Ifenprodil))

Completed
Has Results
  • COVID
  • NP-120 (Ifenprodil)
  • Miami, Florida
  • +9 more
Dec 1, 2021

Advanced Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

B-cell Non-Hodgkin's Lymphoma Trial (Fully Human Anti-CD19/CD22 Dual Target Chimeric Antigen Receptor Autologous T Cell

Not yet recruiting
  • B-cell Non-Hodgkin's Lymphoma
  • Fully Human Anti-CD19/CD22 Dual Target Chimeric Antigen Receptor Autologous T Cell Injection
  • (no location specified)
Oct 12, 2021

Covid19 Trial in Argentina, Brazil, United States (rNAPc2, Heparin)

Completed
  • Covid19
  • Fairhope, Alabama
  • +23 more
May 25, 2022

Corona Virus Infection Trial in Worldwide (SAR443122, Placebo)

Completed
  • Corona Virus Infection
  • Caba, Argentina
  • +9 more
Apr 21, 2022

COVID-19 Trial in United States (Camostat Mesilate, Placebo)

Completed
Has Results
  • COVID-19
  • Camostat Mesilate
  • Placebo
  • Palm Springs, California
  • +20 more
Jan 13, 2022

COVID, Covid-19, Coronavirus Trial in Brazil, United States (APL-9, Vehicle Control)

Completed
Has Results
  • COVID
  • +8 more
  • Fresno, California
  • +23 more
Mar 21, 2022

COVID-19 Trial in Worldwide (ADG20, Normal saline)

Terminated
  • COVID-19
  • Estomba, Buenos Aires, Argentina
  • +67 more
Nov 22, 2022

Alzheimer, Alzheimer 1, Alzheimer 2 Trial in United States (Sensory Stimulation System (GS120) - Active, Sensory Stimulation

Recruiting
  • Alzheimer Disease
  • +34 more
  • Sensory Stimulation System (GS120) - Active
  • Sensory Stimulation System (GS120) - Sham
  • Washington, District of Columbia
  • +24 more
Jan 27, 2023

Viral Disease Trial in Worldwide (PF-07304814, Placebo)

Completed
  • Viral Disease
  • Mountain View, California
  • +12 more
Jun 23, 2021

Covid19 Trial in Worldwide (VIR-7831, Placebo)

Completed
Has Results
  • Covid19
  • VIR-7831 (sotrovimab)
  • Placebo
  • Anniston, Alabama
  • +90 more
Oct 12, 2022

Corona Virus Infection Trial in Worldwide (Sarilumab SAR153191, Placebo)

Completed
Has Results
  • Corona Virus Infection
  • Sarilumab SAR153191
  • Placebo
  • Caba, Argentina
  • +46 more
Mar 15, 2022

COVID-19, Lung Infection Trial in Worldwide (Opaganib, Placebo)

Completed
  • COVID-19
  • Lung Infection
  • Detroit, Michigan
  • +56 more
Jul 19, 2021

Coronavirus Disease 2019 Trial in Worldwide (Carrimycin, Placebo)

Recruiting
  • Coronavirus Disease 2019
  • Winfield, Illinois
  • +59 more
Mar 26, 2022

Immunosuppression, COVID-19 Trial in Madison (NVX-CoV2372)

Not yet recruiting
  • Immunosuppression
  • COVID-19
  • NVX-CoV2372
  • Madison, Wisconsin
    UW School of Medicine and Public Health
Aug 31, 2023